Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients ...

In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

The first ‘real-world study’ into the weight loss drug, Mounjaro, has now started in Greater Manchester. Thousands of ...

The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...

One of the reasons for the internal disagreement at the club was the fact that the nutritionist Eduardo Rauen, who has been ...

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Love Is Blind alum Irina Solomonova has been using a GLP-1 to slim down. “I’m finishing my first month on GLP-1s. I’m on ...